paediatrics Brussels 17

Ependymoma / outcome according to R0/+ and dose escalation Intracranial ependymoma

Group

Pat.

PFS

OS

Milan 2004

63 (hfx . 46 children)

5 years R0 : 65% R+ : 35%

5 years 82% 61% 5 years 73.7% 80%

SFOP 2009

24 (hfx 60/66Gy)

5 years

St. Jude 2009

153

7 years R0 : 77.3% R+ : 34.2% 7 years R0 : 68.7% R+ : 47.6 %

7 years R0 : 88.0% R+ : 52.4% 7 years R0 : 82.7% R+ : 67.1%

HIT 2000 (interim analysis)

181